BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kai K, Satake M, Tokunaga O. Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature. World J Gastroenterol 2018; 24(26): 2915-2920 [PMID: 30018486 DOI: 10.3748/wjg.v24.i26.2915] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Wu X, Yang S, Yang X, Yao J, Zheng H. Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection. Diagn Pathol 2020;15:131. [PMID: 33097069 DOI: 10.1186/s13000-020-01047-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ueyama H, Yao T, Akazawa Y, Hayashi T, Kurahara K, Oshiro Y, Yamada M, Oda I, Fujioka S, Kusumoto C, Fukuda M, Uchita K, Kadota T, Oono Y, Okamoto K, Murakami K, Matsuo Y, Kato M, Maehata T, Yahagi N, Yasuhara Y, Yada T, Uraushihara K, Yamane T, Matsuo T, Ito M, Maruyama Y, Osako A, Ono S, Kato M, Yagi K, Hashimoto T, Tomita N, Tsuyama S, Saito T, Matsumoto K, Matsumoto K, Watanabe S, Uemura N, Chiba T, Nagahara A. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol 2021;56:814-28. [PMID: 34268625 DOI: 10.1007/s00535-021-01813-z] [Reference Citation Analysis]
3 Gao S, Li X, Shi W, Huo L, Liu H, Zhong WL. Efficacy of the Low Dose Apatinib plus Chemotherapy on Advanced Gastric Carcinoma. Journal of Oncology 2022;2022:1-5. [DOI: 10.1155/2022/3009494] [Reference Citation Analysis]
4 Xu G, Fan L, Zhao S, OuYang C. MT1G inhibits the growth and epithelial-mesenchymal transition of gastric cancer cells by regulating the PI3K/AKT signaling pathway. Genet Mol Biol 2022;45:e20210067. [PMID: 35167648 DOI: 10.1590/1678-4685-GMB-2021-0067] [Reference Citation Analysis]
5 Liu C, Sun W, Yang K, Xia B. Knockdown of TRIM65 suppressed the proliferation and invasiveness of gastric cancer cells by restricting the ubiquitin degradation of PPM1A. Exp Cell Res 2022;:113154. [PMID: 35421368 DOI: 10.1016/j.yexcr.2022.113154] [Reference Citation Analysis]
6 Meng X, Yang G, Dong C, Zheng R. Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis. Rare Tumors 2021;13:203636132110601. [DOI: 10.1177/20363613211060171] [Reference Citation Analysis]
7 Wang X, Qiu Z, Ji X, Ning W, An Y, Wang S, Zhang H. A novel workflow for cancer blood biomarker identification. Ann Transl Med 2020;8:1430. [PMID: 33313175 DOI: 10.21037/atm-20-2047] [Reference Citation Analysis]
8 Liu L, Han L, Ma Q, Zhang J. Gastric adenocarcinoma of fundic gland (chief cell predominant type) coexisting with well differentiated intestinal adenocarcinoma: A case report. Medicine (Baltimore) 2021;100:e25861. [PMID: 34032698 DOI: 10.1097/MD.0000000000025861] [Reference Citation Analysis]
9 Xia L, Sun S, Dai W, Hussein AF. Deep Learning-Based Ultrasound Combined with Gastroscope for the Diagnosis and Nursing of Upper Gastrointestinal Submucous Lesions. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/1607099] [Reference Citation Analysis]
10 Han W, Bu X, Liu Y, Liu F, Ren Y, Cui Y, Kong S. Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer. World J Surg Oncol 2021;19:283. [PMID: 34537058 DOI: 10.1186/s12957-021-02395-z] [Reference Citation Analysis]